Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Herbert v. Barr Laboratories, Inc., et al
Case Number:
8:12-cv-00845
Court:
Nature of Suit:
Judge:
Firms
-
August 07, 2012
Barr Uses Mensing To Escape Generic Accutane Case
A federal judge in Florida on Monday wiped out claims from a man diagnosed with inflammatory bowel disease after taking a generic version of Accutane, a blow to multidistrict litigation involving Barr Laboratories Inc. and the latest case derailed by the U.S. Supreme Court's Pliva v. Mensing decision.
-
July 10, 2012
Barr Seeks To Use Mensing As Shield In Accutane MDL
Barr Laboratories Inc. on Monday argued that failure-to-warn claims from a man diagnosed with inflammatory bowel disease after using generic Accutane are blocked by the U.S. Supreme Court's Pliva Inc. v. Mensing ruling, as it sought to escape multidistrict litigation over the acne drug.